Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.71% |
| 2 | Healthcare | 14.72% |
| 3 | Consumer Discretionary | 14.64% |
| 4 | Industrials | 11.02% |
| 5 | Consumer Staples | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Santander
BSBR
$43.3B
| $1.19M | ﹤0.01% |
176,692
| – | – |
|
1477
Pitney Bowes
PBI
$2.27B
| $1.19M | ﹤0.01% |
144,704
+112,281
| +346% | +$963K |
|
1478
Blue Bird Corp
BLBD
$1.87B
| $1.19M | ﹤0.01% |
47,459
+30,402
| +178% | +$694K |
|
1479
Buckle
BKE
$2.29B
| $1.19M | ﹤0.01% |
30,229
+2,379
| +9% | +$89.6K |
|
1480
CarGurus
CARG
$3.31B
| $1.18M | ﹤0.01% |
49,569
+13,466
| +37% | +$390K |
|
|
AGR
1481
DELISTED
Avangrid, Inc.
AGR
| $1.18M | ﹤0.01% |
23,721
-74,535
| -76% | -$3.49M |
|
|
SFBS
1482
ServisFirst Bancshares
SFBS
$4.8B
| $1.17M | ﹤0.01% |
38,114
+276
| +0.7% | +$6.85K |
|
1483
Knowles
KN
$2.78B
| $1.17M | ﹤0.01% |
55,841
-9,266
| -14% | -$189K |
|
|
RJET
1484
Republic Airways Holdings
RJET
$879M
| $1.17M | ﹤0.01% |
5,774
+3,471
| +151% | +$546K |
|
1485
Iridium Communications
IRDM
$5.01B
| $1.16M | ﹤0.01% |
28,166
-3,080
| -10% | -$135K |
|
1486
W.P. Carey
WPC
$16.3B
| $1.16M | ﹤0.01% |
16,771
+11,018
| +192% | +$739K |
|
|
TWOU
1487
DELISTED
2U Inc
TWOU
| $1.15M | ﹤0.01% |
1,009
+217
| +27% | +$275K |
|
|
ABTX
1488
DELISTED
Allegiance Bancshares
ABTX
| $1.15M | ﹤0.01% |
+28,343
| New | +$1.08M |
|
|
CHX
1489
DELISTED
ChampionX
CHX
| $1.15M | ﹤0.01% |
53,982
+16,753
| +45% | +$326K |
|
|
TSE
1490
DELISTED
Trinseo
TSE
| $1.15M | ﹤0.01% |
+18,008
| New | +$1.1M |
|
|
GTLS
1491
DELISTED
Chart Industries
GTLS
| $1.15M | ﹤0.01% |
8,042
+206
| +3% | +$29.1K |
|
1492
Travere Therapeutics
TVTX
$6.15B
| $1.14M | ﹤0.01% |
45,801
+15,944
| +53% | +$441K |
|
|
SRNE
1493
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.14M | ﹤0.01% |
138,284
+17,373
| +14% | +$183K |
|
|
SAIL
1494
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $1.14M | ﹤0.01% |
22,805
-10,649
| -32% | -$599K |
|
1495
Vicor
VICR
$8.76B
| $1.14M | ﹤0.01% |
13,407
-2,597
| -16% | -$244K |
|
1496
E.W. Scripps
SSP
$308M
| $1.14M | ﹤0.01% |
+58,945
| New | +$1.08M |
|
1497
TFS Financial
TFSL
$4.95B
| $1.13M | ﹤0.01% |
55,660
-40,838
| -42% | -$796K |
|
|
CSGS
1498
DELISTED
CSG Systems International
CSGS
| $1.13M | ﹤0.01% |
25,141
-1,709
| -6% | -$78.8K |
|
1499
Five Below
FIVE
$14.5B
| $1.13M | ﹤0.01% |
5,990
+1,427
| +31% | +$269K |
|
|
SRDX
1500
DELISTED
Surmodics
SRDX
| $1.12M | ﹤0.01% |
20,019
+319
| +2% | +$15.9K |
|
Similar funds
Cliff Asness's Q1 2021 Portfolio in Review
As of Q1 2021, Cliff Asness held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cliff Asness's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Cliff Asness's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- Cliff Asness added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- Cliff Asness's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- Cliff Asness fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- Cliff Asness's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- Cliff Asness opened 154 new positions and closed 154 in Q1 2021.
- Cliff Asness's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.